Reperfusion facilitates reversible disruption of the human blood-brain barrier following acute ischaemic stroke

Eur Radiol. 2018 Feb;28(2):642-649. doi: 10.1007/s00330-017-5025-3. Epub 2017 Aug 30.

Abstract

Objectives: We aimed to detect early changes of the blood-brain barrier permeability (BBBP) in acute ischaemic stroke (AIS), with or without reperfusion, and find out whether BBBP can predict clinical outcomes.

Methods: Consecutive AIS patients imaged with computed tomographic perfusion (CTP) before and 24 h after treatment were included. The relative permeability-surface area product (rPS) was calculated within the hypoperfused region (rPShypo-i), non-hypoperfused region of ischaemic hemisphere (rPSnonhypo-i) and their contralateral mirror regions (rPShypo-c and rPSnonhypo-c). The changes of rPS were analysed using analysis of variance (ANOVA) with repeated measures. Logistic regression was used to identify independent predictors of unfavourable outcome.

Results: Fifty-six patients were included in the analysis, median age was 76 (IQR 62-81) years and 28 (50%) were female. From baseline to 24 h after treatment, rPShypo-i, rPSnonhypo-i and rPShypo-c all decreased significantly. The decreases in rPShypo-i and rPShypo-c were larger in the reperfusion group than non-reperfusion group. The rPShypo-i at follow-up was a predictor for unfavourable outcome (OR 1.131; 95% CI 1.018-1.256; P = 0.022).

Conclusion: Early disruption of BBB in AIS is reversible, particularly when greater reperfusion is achieved. Elevated BBBP at 24 h after treatment, not the pretreatment BBBP, predicts unfavourable outcome.

Key points: • Early disruption of blood-brain barrier (BBB) in stroke is reversible after treatment. • The reversibility of BBB permeability is associated with reperfusion. • Unfavourable outcome is associated with BBB permeability at 24 h after treatment. • Contralateral non-ischaemic hemisphere is not 'normal' during an acute stroke.

Keywords: Blood–brain barrier; Computed tomography; Outcome; Reperfusion; Stroke.

MeSH terms

  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Blood-Brain Barrier / metabolism*
  • Brain Ischemia / diagnosis*
  • Brain Ischemia / metabolism
  • Contrast Media / administration & dosage
  • Contrast Media / pharmacokinetics*
  • Female
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Multidetector Computed Tomography / methods*
  • Permeability
  • Tomography, X-Ray Computed / methods*

Substances

  • Contrast Media